Integra LifeSciences

(NASDAQ) IART

Current Price$10.72

Market Cap$831.96M

Since IPO (1995)+156%

5 Year-86%

1 Year-36%

1 Month+16%

Integra LifeSciences Financials at a Glance

Market Cap

$831.96M

Revenue (TTM)

$1.64B

Net Income (TTM)

$516.47M

EPS (TTM)

$-6.73

P/E Ratio

-1.59

Dividend

$0.00

Beta (Volatility)

1.07 (Average)

Dividend

$0.00

Beta (Volatility)

1.07 (Average)

Price

$10.72

Volume

904,976.271

Open

$10.76

Price

$10.72

Volume

904,976.271

Open

$10.76

Previous Close

$10.74

Daily Range

$10.44 - $10.86

52-Week Range

$8.70 - $17.54

Dividend

$0.00

Beta (Volatility)

1.07 (Average)

Price

$10.72

Volume

904,976.271

Open

$10.76

Previous Close

$10.74

Daily Range

$10.44 - $10.86

52-Week Range

$8.70 - $17.54

IART News

Integra Beats on the Bottom Line

Rich DupreyOct 29, 2013

A Solid Orthopedic Implants Manufacturer

Kanak KantiAug 22, 2013

Integra LifeSciences Holdings Beats Expectations But Takes A Step Back Anyway

Seth JaysonAug 1, 2013

Page 1

IART: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Integra LifeSciences

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

4,427

CEO

Mojdeh Poul, MBA

Website

www.integralife.com

Headquarters

Princeton, NJ 08540, US

IART Financials

Key Financial Metrics (TTM)

Gross Margin

52%

Operating Margin

Net Income Margin

-32%

Return on Equity

-40%

Return on Capital

Return on Assets

-14%

Earnings Yield

-62.89%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$831.96M

Shares Outstanding

77.83M

Volume

904.98K

Avg. Volume

806.54K

Financials (TTM)

Gross Profit

$845.23M

Operating Income

$68.32M

EBITDA

$326.20M

Operating Cash Flow

$50.38M

Capital Expenditure

$81.44M

Free Cash Flow

$31.05M

Cash & ST Invst.

$263.74M

Total Debt

$2.03B

Integra LifeSciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$434.93M

-1.7%

Gross Profit

$215.36M

-13.5%

Gross Margin

49.52%

N/A

Market Cap

$831.96M

N/A

Market Cap/Employee

$189.25K

N/A

Employees

4,396

N/A

Net Income

$1.70M

-108.8%

EBITDA

$65.99M

-16.6%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$1.77B

-3.4%

Accounts Receivable

$278.85M

+2.4%

Inventory

$492.74M

+14.8%

Long Term Debt

$1.89B

+38.9%

Short Term Debt

$140.57M

-77.4%

Return on Assets

-14.34%

N/A

Return on Invested Capital

2.17%

N/A

Free Cash Flow

$37.25M

-433.0%

Operating Cash Flow

$11.82M

-76.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

INMDInMode Ltd.

INMDInMode Ltd.$14.21-0.70%

MRVIMaravai LifeSciences Holdings, Inc.

MRVIMaravai LifeSciences Holdings, Inc.$3.56-3.26%

FTREFortrea Holdings Inc.

FTREFortrea Holdings Inc.$10.76+1.51%

SEPNSepterna, Inc.

SEPNSepterna, Inc.$24.29-3.19%

EYPTEyePoint Pharmaceuticals, Inc.

EYPTEyePoint Pharmaceuticals, Inc.$13.47-0.96%

PACBPacific Biosciences of California, Inc.

PACBPacific Biosciences of California, Inc.$1.58-0.63%

BCAXBicara Therapeutics Inc. Common Stock

BCAXBicara Therapeutics Inc. Common Stock$21.92-2.47%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$84.52-0.01%

NOKNokia

NOKNokia$11.30+0.05%

POETPoet Technologies

POETPoet Technologies$8.03+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$60.74-0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.14-0.01%

SOFISoFi Technologies

SOFISoFi Technologies$18.36-0.02%

RIGTransocean

RIGTransocean$6.79+0.04%

Questions About IART

What is the current price of Integra LifeSciences?

Integra LifeSciences is trading at $10.74 per share.

What is the 52-week range for Integra LifeSciences?

Over the past 52 weeks, Integra LifeSciences has traded between $8.70 and $17.54.

How much debt does Integra LifeSciences have?

As of the most recent reporting period, Integra LifeSciences reported total debt of $2.03B.

How much cash does Integra LifeSciences have on hand?

Integra LifeSciences reported $235.05M in cash and cash equivalents in its most recent financial results.

What is Integra LifeSciences’s dividend yield?

Integra LifeSciences does not currently have a dividend yield.

Integra LifeSciences

Integra LifeSciences Financials at a Glance

IART News

Integra (IART) Q2 Revenue Beats by 5%

Why Integra Lifesciences Stock Is Sinking Today

Why Integra LifeSciences Stock Is Crashing Today

Here's Why Integra LifeSciences Holdings Corp. Is Sinking Today

Integra LifeSciences' Stock Split: Why It Accomplished Nothing

Integra Beats on the Bottom Line

A Solid Orthopedic Implants Manufacturer

Integra LifeSciences Holdings Beats Expectations But Takes A Step Back Anyway

IART: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Integra LifeSciences

IART Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Integra LifeSciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About IART

What is the current price of Integra LifeSciences?

What is the 52-week range for Integra LifeSciences?

How much debt does Integra LifeSciences have?

How much cash does Integra LifeSciences have on hand?

What is Integra LifeSciences’s dividend yield?

Premium Investing Services